Who owns the IMPLAVAX trademark?

The IMPLAVAX trademark is owned by Enesi Pharma Limited.

What class is the IMPLAVAX trademark registered in?

The IMPLAVAX trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for IMPLAVAX?

The USPTO serial number for IMPLAVAX is 79296059.

What is the registration number for IMPLAVAX?

IMPLAVAX is registered under USPTO registration number 6458326.

Sealvo

Home Search: IMPLAVAXIMPLAVAX #79296059

Back

Updated Oct 14, 2026·16 searches this week

View on USPTO TSDR Find similar marks

IMP

USPTO Trademark Record

REGISTERED

IMPLAVAX

SN 79296059·Reg 6458326·Filed Sep 03, 2020

Owner Enesi Pharma Limited

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

IMPLAVAX (Serial No. 79296059), Registration No. 6458326, is a registered US trademark filed on Sep 03, 2020 by Enesi Pharma Limited. This trademark covers Class 042 (Scientific, technology & SaaS services).

Renewal window: August 24, 2027314 days remaining

Mark Intelligence

IMPLAVAX (Reg. #6458326) is a registered US trademark that has been protecting its owner, Enesi Pharma Limited, since 2020. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 03, 2020

SERIAL

79296059

REG#

6458326

REGISTERED

Aug 24, 2021

Filing Information

StatusREGISTERED

Filing DateSep 03, 2020

Serial Number79296059

Registration No.6458326

Registration DateAug 24, 2021

Status DateAug 24, 2021

Published for OppositionJun 08, 2021

Filing Basis & Declarations

Standard Characters Claimed

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

26 events

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Aug 24, 2026

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

FINAL DECISION TRANSACTION PROCESSED BY IB

Feb 28, 2022

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION NOTICE SENT TO IB

Feb 04, 2022

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION PROCESSED

Feb 03, 2022

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Nov 24, 2021

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Aug 24, 2021

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Jun 08, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 08, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 19, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 03, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 27, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 26, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 26, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

LIMITATION FROM THE IB - REQUEST EXAM REVIEW

Mar 22, 2021

LIMITATION FROM THE IB - REQUEST EXAM REVIEW

ATTORNEY REVIEW COMPLETED

Mar 22, 2021

ATTORNEY REVIEW COMPLETED

LIMITATION OF GOODS RECEIVED FROM IB

Jan 08, 2021

LIMITATION OF GOODS RECEIVED FROM IB

REFUSAL PROCESSED BY IB

Dec 20, 2020

REFUSAL PROCESSED BY IB

CHANGE OF NAME/ADDRESS REC'D FROM IB

Dec 11, 2020

CHANGE OF NAME/ADDRESS REC'D FROM IB

REFUSAL PROCESSED BY MPU

Dec 01, 2020

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Dec 01, 2020

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Nov 10, 2020

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Nov 09, 2020

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Nov 02, 2020

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Oct 23, 2020

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 19, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Oct 15, 2020

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks by Enesi Pharma Limited

Additional USPTO filings from the same owner.

ENE

ENESI

79296907

Enesi Pharma Limited

REGISTERED

IMP

IMPLAVAX

79233134

Enesi Pharma Limited

ABANDONED

Other Marks by Rebecca Liebowitz

Additional USPTO filings handled by the same attorney of record.

QUI

QUICKFLEX WALLS

88171077

REGISTERED

SNI

SNIPES

79247185

REGISTERED

SNI

SNIPES

79247183

REGISTERED

MAK

MAK.CARE

99426929

REGISTERED

IMPLAVAX

Run a conflict check

Other Marks by Enesi Pharma Limited

Other Marks by Rebecca Liebowitz

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company